Association Between Clinically Meaningful Improvements in Patient-Reported Outcomes and Stringent Measures of Disease Activity in Patients with Psoriatic Arthritis Treated with Upadacitinib versus Placebo or Adalimumab: Results from a Phase 3 Trial

Gossec, Laure; Damjanov, Nemanja S; Tsuji, Shigeyoshi; Lertratanakul, Apinya; Lippe, Ralph; Patel, Jayeshkumar; Zueger, Patrick; De, Vlam Kurt

Rezultati

eNauka > Rezultati > Association Between Clinically Meaningful Improvements in Patient-Reported Outcomes and Stringent Measures of Disease Activity in Patients with Psoriatic Arthritis Treated with Upadacitinib versus Placebo or Adalimumab: Results from a Phase 3 Trial

Naziv :	Association Between Clinically Meaningful Improvements in Patient-Reported Outcomes and Stringent Measures of Disease Activity in Patients with Psoriatic Arthritis Treated with Upadacitinib versus Placebo or Adalimumab: Results from a Phase 3 Trial
Autori:	Gossec, Laure; Damjanov, Nemanja S; Tsuji, Shigeyoshi; Lertratanakul, Apinya; Lippe, Ralph; Patel, Jayeshkumar; Zueger, Patrick; De, Vlam Kurt
Godina:	2021
Publikacija:	ARTHRITIS & RHEUMATOLOGY
ISSN:	2326-5191 Arthritis & Rheumatology Pretraži identifikator
Tip rezultata:	Konferencijski rad
Kolacija:	vol. 73 str. 3986-3989
WoS-ID:	000744545207224
URI:	https://enauka.gov.rs/handle/123456789/819044
Izvor metapodataka:	(Preuzeto iz Nasi u WoS)
M-kategorija:	Mp kategorija će biti prikazana naknadno.

1
WEB OF SCIENCE^TM

Pronađi DOI

Pronalaženje DOI u servisu CrossRef-u na osnovu meta-podataka u zapisu. Prikazaće se DOI (i metapodaci) čiji se podaci najviše poklapaju. OPREZ - to ne mora biti ta publikacija.

Google Scholar^TM

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.